Malleable penile prosthesis is a cost-effective treatment for refractory ischemic priapism

Timothy J. Tausch, Lee C. Zhao, Allen F. Morey, Jordan A. Siegel, Michael J. Belsante, Casey A. Seideman, James R. Flemons

    Research output: Contribution to journalArticle

    19 Scopus citations

    Abstract

    Introduction: Refractory ischemic priapism (RIP) can be difficult to treat, consuming significant healthcare-related resources. Acute insertion of a malleable penile prosthesis (MPP) has been reported as an effective therapy that treats the priapism and restores sexual function. Aim: We report our 6-year, urban public hospital experience with acute insertion of MPP in patients with RIP. Methods: We retrospectively reviewed the records of patients receiving MPPs for RIP from 2007 to 2013. Data analyzed included duration of erection, number of emergency room (ER) visits, hospital admissions, days of hospitalization, and postoperative course. Costs were estimated using standard Medicare reimbursement rates. Main Outcome Measure: Healthcare-related costs of treatment of RIP episodes in men presenting to our institution. Results: During the study period, 14 men underwent MPP placement acutely for refractory priapism. Thirteen presented with RIP, and one had stuttering priapism over a 14-day hospitalization. Etiologies included sickle cell anemia (4/13, 29%), medication-induced (3/14, 21%), and idiopathic (7/14, 50%). Average preoperative duration of RIP was 82 hours with considerable consumption of health-care resources (average US $83,818 estimated cost, 4 ER visits [range 1-27], 2 hospital admissions [range 1-5], 1.5 shunt procedures [range 1-3], 5 irrigation and drainage procedures using phenylephrine injection [range 2-20], and 5 hospital admission days [range 2-14]). All patients were discharged within 24 hours of MPP surgery. Conclusions: The management of RIP is associated with multiple ER visits, prolonged hospital admissions, and significant resource utilization. MPP insertion is efficacious for the immediate resolution of refractory priapism, with potential cost and resource benefits.

    Original languageEnglish (US)
    Pages (from-to)824-826
    Number of pages3
    JournalJournal of Sexual Medicine
    Volume12
    Issue number3
    DOIs
    StatePublished - Mar 1 2015

      Fingerprint

    Keywords

    • Erectile dysfunction
    • Penile prosthesis
    • Priapism

    ASJC Scopus subject areas

    • Reproductive Medicine
    • Obstetrics and Gynecology
    • Urology

    Cite this

    Tausch, T. J., Zhao, L. C., Morey, A. F., Siegel, J. A., Belsante, M. J., Seideman, C. A., & Flemons, J. R. (2015). Malleable penile prosthesis is a cost-effective treatment for refractory ischemic priapism. Journal of Sexual Medicine, 12(3), 824-826. https://doi.org/10.1111/jsm.12803